Pharma Aids Balance Sheet Health
Financial Health criteria checks 6/6
Pharma Aids has a total shareholder equity of BDT339.0M and total debt of BDT3.9M, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are BDT456.5M and BDT117.5M respectively. Pharma Aids's EBIT is BDT76.2M making its interest coverage ratio 315.4. It has cash and short-term investments of BDT50.1M.
Key information
1.1%
Debt to equity ratio
৳3.87m
Debt
| Interest coverage ratio | 315.4x |
| Cash | ৳50.15m |
| Equity | ৳338.96m |
| Total liabilities | ৳117.53m |
| Total assets | ৳456.50m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PHARMAID's short term assets (BDT394.7M) exceed its short term liabilities (BDT117.4M).
Long Term Liabilities: PHARMAID's short term assets (BDT394.7M) exceed its long term liabilities (BDT141.1K).
Debt to Equity History and Analysis
Debt Level: PHARMAID has more cash than its total debt.
Reducing Debt: PHARMAID's debt to equity ratio has reduced from 7.7% to 1.1% over the past 5 years.
Debt Coverage: PHARMAID's debt is well covered by operating cash flow (775.6%).
Interest Coverage: PHARMAID's interest payments on its debt are well covered by EBIT (315.4x coverage).